Why invest in anti-ageing medicine?
Enlarge your life
We may not be able to avoid death, but what if we could put it off and live up to fifty more years? More and more people believe it is possible to do so.
To avoid age-related illnesses
We live in an increasingly older society, and this is a trend that should continue. It is crucial to invest in anti-ageing medicine to ensure that not only do we live longer, but that we do so in a much better way, avoiding those diseases related to ageing.
To reduce healthcare cost
In economic terms, the extension and improvement of people's quality of life would have an exponential positive effect, as it would make economies more productive, while at the same time producing significant savings in health care costs that could be used for other purposes.
How do we invest in anti-ageing medicine?
We have selected the most relevant companies and investment vehicles worldwide to invest in anti-ageing medicine:
Una acción representa una parte alícuota del capital social de una empresa. El comprador se convierte en socio de la empresa, en el porcentaje acorde al número de acciones compradas.
Los ETFs (Exchange Trade Funds) son un tipo de fondo de inversión, que cotiza diariamente en el mercado y que generalmente tratan de replicar un índice bursátil, por ejemplo de un país o de un sector.
Un fondo de inversión es un vehículo de inversión que aglutina las aportaciones de distintos inversores para invertirlos en una cesta de empresas u otros activos.
|Name||ISIN||Market||Currency||CCY Hedged||Download||Go to....|
Legal disclaimer & warnings
The information contained herein is only provided for informative purposes, and it does not constitute an offer, invitation or incitement to sell, buy or subscribe shares, nor should it be
interpreted as such. For legal reasons, in some states this information cannot be divulged to persons with nationality or legal residence in a state where the admission of the products
described herein is limited. The prices of the products described herein may rise or fall. References to past returns do not presuppose, predispose or condition returns in the future.
The return does not take account of the fees and rates charged when buying and selling the investment. The return from a particular portfolio may differ from that of the aggregate for numerous reasons, therefore said returns are stated merely for guidance and are under no way a guarantee of the return to be attained. Likewise, past returns do not assure future returns. Further information will be provided upon request. As compensation for its services or for other motives, BBVA SA may receive one-off or repeated remunerations (for example, issue premiums or placement fees). In certain circumstances the interests of BBVA SA may enter into conflict with those of the investor. Please contact your Investment Advisor for further information.
The publication or distribution of all or part of this documentation is prohibited unless prior written authorisation is granted by BBVA SA. Furthermore, certain information herein is based on or derives from information that is generally available to the public at large and from sources we consider to be reliable; however, no guarantee is offered with regard to its exactness. The sale of some of the investments in the portfolio may be restricted in the United States or to citizens from that country. This information cannot be sent, taken to or distributed in the United States nor can it be supplied to any person from the USA. It does not constitute a public securities offering, controlled, supervised or regulated by Central Banks, Authorities or Regulators from certain overseas countries, such as the United Kingdom, Peru, Turkey, El Salvador, Uruguay, Paraguay or Costa Rica.
News about anti-ageing medicine
Maintaining the experience and quality of BBVA, New Gen is presented as an option to invest from scratch or with small or medium capital and offers you an extensive portfolio of companies of global interest to give you the possibility not only to invest, but do it on purpose.
Currently, life expectancy is over 70 years in almost every country in the world. This presents a challenge for authorities and governments, who find it necessary to adapt certain elements to adjust to this reality. The increasing increase in longevity has also become a major investment trend, leading to the question of what has caused this increase?
After the pandemic, people are resuming or acquiring healthy habits for their physical and mental well-being, mainly as a way to strengthen their immune system and to restore lost health.
The main drivers of the sector are anti-aging products such as moisturizers, which grew 10.7%, and hair care products, with 8.5% growth.
It is estimated that by the year 2050, one out of every six people in the world will be over 65 years old, which corresponds to 16% of the population, while the number of people aged 80 and over will triple, reaching 426 million.
By 2050, 20% of the world's population will be over 60 years of age and, in turn, this will be more than the population under 5 years of age. Not only has the fertility rate been decreasing, but life expectancy has been increasing thanks to technological advances in food, medicine and the globalization of work.